Alnylam Pharmaceuticals, Inc.
ALNY
$438.93
$3.830.88%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.56% | -2.31% | -3.08% | 5.93% | 10.68% |
| Total Receivables | 35.66% | 3.14% | 14.54% | 14.34% | -3.70% |
| Inventory | 9.31% | -16.47% | 3.32% | -9.52% | -10.65% |
| Prepaid Expenses | -3.35% | 30.31% | -19.53% | -6.07% | -23.38% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 11.49% | -0.82% | -1.79% | 5.75% | 6.17% |
|
|
|||||
| Total Current Assets | 11.49% | -0.82% | -1.79% | 5.75% | 6.17% |
| Net Property, Plant & Equipment | -0.54% | 0.29% | -1.35% | -1.69% | -0.48% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -7.81% | -0.45% | 71.51% | 20.52% | 3.82% |
| Total Assets | 8.36% | -0.62% | 0.83% | 4.87% | 4.84% |
|
|
|||||
| Total Accounts Payable | 5.13% | 10.16% | 24.87% | -4.29% | -5.33% |
| Total Accrued Expenses | 30.50% | -11.44% | -15.96% | 17.01% | 15.71% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 12.38% | -17.49% | 16.77% | 28.03% | 17.96% |
| Total Finance Division Other Current Liabilities | -7.10% | -1.04% | 108.07% | 2.93% | -10.20% |
| Total Other Current Liabilities | -7.10% | -1.04% | 108.07% | 2.93% | -10.20% |
| Total Current Liabilities | 20.94% | -9.33% | -2.82% | 15.68% | 12.06% |
|
|
|||||
| Total Current Liabilities | 20.94% | -9.33% | -2.82% | 15.68% | 12.06% |
| Long-Term Debt | 0.31% | 0.23% | 0.06% | -0.33% | 0.28% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -2.44% | 0.23% | -2.75% | -1.39% | 0.64% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -2.30% | 7.59% | 11.05% | 1.60% | -30.20% |
| Total Liabilities | 5.30% | -1.79% | 0.01% | 3.99% | -0.77% |
|
|
|||||
| Common Stock & APIC | 2.59% | 1.47% | 1.77% | 1.93% | 3.50% |
| Retained Earnings | -0.90% | -0.79% | -1.16% | -1.57% | -0.24% |
| Treasury Stock & Other | 20.16% | -8.69% | -39.04% | 28.33% | -28.34% |
| Total Common Equity | 117.08% | 72.07% | 107.36% | 1,154.91% | 98.60% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 117.08% | 72.07% | 107.36% | 1,154.91% | 98.60% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 117.08% | 72.07% | 107.36% | 1,154.91% | 98.60% |
|
|
|||||